treatment of hair loss

Répondre


Veuillez compléter la vérification suivante afin de nous permettre de lutter contre les publications automatisées indésirables.
Émoticônes
:wink: :smile: :thumbup: :headphone: :sad: :scare: :rolling: :cool: :think: :thumbdown: :music: :crying: :shock: |( ;) :excellent: }:) {:| ;( :) :(
   

Agrandir Relecture du sujet : treatment of hair loss

treatment of hair loss

par tcsindustryk » 30 sept. 2022, 11:50

RU-58841, also known as PSK-3841 or HMR-3841, is a nonsteroidal antiandrogen (NSAA) which was initially developed in the 1980s by Roussel Uclaf, the French pharmaceutical company from which it received its name. It was formerly under investigation by ProStrakan (previously ProSkelia and Strakan) for potential use as a topical treatment for androgen-dependent conditions including acne, pattern hair loss,[1] and excessive hair growth. The compound is similar in structure to the NSAA RU-58642 but contains a different side-chain.

Haut